Skip to content
HowShorted

REATA PHARMACEUTICALS INC short interest in 2023

In 2023, REATA PHARMACEUTICALS INC's disclosed short interest ran from 22.20% of shares outstanding on 13 Jan 2023 to 6.28% on 15 Sep 2023, a change of -15.92 percentage points. The year's high was 24.05% on 15 Feb 2023 and its low 6.28% on 15 Sep 2023, averaging 13.99% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.96 days on 13 Jan 2023. Full history: REATA PHARMACEUTICALS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for REATA PHARMACEUTICALS INC in 2023

2023 in figures

Start of year
22.20% (13 Jan 2023)
End of year
6.28% (15 Sep 2023)
Change
-15.92 pp
High
24.05% (15 Feb 2023)
Low
6.28% (15 Sep 2023)
Average
13.99%
Highest days to cover
14.96 (13 Jan 2023)
SEC filings marked
4

Every report in 2023

REATA PHARMACEUTICALS INC short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202322.20%14.96
31 Jan 202322.94%11.80
15 Feb 202324.05%10.85
28 Feb 202322.75%2.1910-K filed
15 Mar 202313.69%1.76
31 Mar 202313.73%6.99
14 Apr 202314.09%9.39
28 Apr 202313.05%10.90
15 May 202313.65%4.9310-Q filed, results (8-K)
31 May 202311.59%4.20
15 Jun 202310.43%5.69
30 Jun 202310.67%4.53
14 Jul 202310.20%8.59
31 Jul 202310.75%2.16
15 Aug 202311.01%4.2410-Q filed
31 Aug 20236.80%4.00
15 Sep 20236.28%3.09

See also: REATA PHARMACEUTICALS INC's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.